Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03921879
Title Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncotartis, Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham RECRUITING Birmingham Alabama 35294 United States Details
City of Hope National Medical Center RECRUITING Duarte California 91010 United States Details
Sylvester Comprehensive Cancer Center RECRUITING Miami Florida 33136 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
Roswell Park Cancer Institute RECRUITING Buffalo New York 14263 United States Details
University Hospitals Seidman Cancer Center RECRUITING Cleveland Ohio 44106 United States Details
Stephenson Cancer Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
Thomas Jefferson University Hospital RECRUITING Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from for the field